Effectiveness loss Subjective but important indicator: Peptide stopped working as well Need higher doses for same effect Complete loss of expected benefits Example: BPC-157 was reducing pain, but suddenly stops helping
Because they address two different bottlenecks in tissue repair: BPC-157 is studied for blood flow and angiogenesis (the supply line), TB-500 for cell migration and actin dynamics (the repair crews mobility)
In both cases, phenomena related to the development of immunological tolerance and the exhaustion of immune system cells are observed [137]
Aquaculture 444, 112.CrossRefGoogle ScholarPubMed Oreochromis niloticus )
CPT1 (CPT1A) deficiency is an extremely rare, autosomal recessively inherited disorder, with only some 60 cases worldwide reported so far
Biochem J 334 (Pt 1), 261267 (1998)